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ABSTRACT 
 
Background:Tuberculous  meningitis  remains  a  serious  clinical  problem.  Missed 
diagnosis and delayed treatment result in significant morbidity and mortality. Aims and 
Objectives:  The  study  was  aimed  to  estimate  the  cerebrospinal  fluid  adenosine 
deaminase  levels  in  clinically  suspected  cases  of  meningitis  and  to  evaluate  the 
usefulness  of  CSF-ADA  as  a  diagnostic  test  in  tuberculosis  meningitis.Methods: 
Adenosine deaminase activity (ADA) was studied in cerebrospinal fluid of 30 cases of 
tuberculous meningitis, 10 cases of pyogenic meningitis. 14 cases of aseptic meningitis 
and  15  controls  (patients  without  any  neurological  disorders  who  were  given  spinal 
anesthesia).Results: The mean cerebrospinal fluid adenosine deaminase activity was 
14.1±1.96; 4.92±1.27; 3.66±1.03 and 1.69±0.44 U/l in tuberculous meningitis, pyogenic 
meningitis,  aseptic  meningitis  and  control  respectively.    The  adenosine  deaminase 
activity in tuberculous meningitis cases was significantly higher.  The sensitivity and 
specificity of this test for diagnosis of tuberculous meningitis was 100% and 97.44% 
respectively with ADA value of more than 10 U/L.  Conclusion: Adenosine deaminase 
activity in CSF is a rapid, relatively inexpensive and easy procedure, can be of great 
value  in  the  early  diagnosis  of  tuberculous  meningitis,  help  in  earlier  institution  of 
appropriate treatment and thereby prevent mortality and complications. 
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INTRODUCTION   
 
Tuberculosis is a burning problem of the world.  
The  global  increase  in  the  incidence  of 
tuberculosis in both immunocompetent as well 
as immunocompromised individuals is a health 
issue of universal concern. Factors that have 
contributed  to  this  increase  are  the  acquired 
immuno-deficiency  syndrome  (AIDS)  and  the 
problem  of  multi-drug-resistant  tuberculosis 
(MDR-TB)
1.  Advanced  age,  alcoholism,  drug 
abuse,  poverty,  malnutrition,  transmigration, 
lymphoma  and  immunosuppressive 
medication  also  contribute  to  increased 
susceptibility
2.  CNS  tuberculosis,  particularly 
tuberculous  meningitis  (TBM)  remains  a 
serious clinical problem. Missed diagnosis and 
delayed treatment result in significant mortality 
and  morbidity.  The  use  of  polymerase  chain 
reaction  (PCR)  to  detect  mycobacterium 
tuberculosis specific DNA may be of potential 
value.  However, the facilities to perform the 
test  are  not  available  in  all  laboratories  and 
many patients are not affordable because of its 
high cost. Adenosine deaminase (ADA) is an 
enzyme  of  purine  catabolism,  catalyzing 
hydrolytic deamination of adenosine to inosine. 
Detection  of  high  level  of  ADA  has  shown 
promising  results  in  the  diagnosis  of 
tuberculous pleural, peritoneal and pericardial 
effusions
3,4.  The  present  study  is  undertaken 
to  assess  the  usefulness  of  adenosine 
deaminase  assay  for  the  diagnosis  of 
tuberculous meningitis. 
 
METHODOLOGY 
 
A total of fifty four cases clinically suspected of 
meningitis, admitted in Basaveshwar  
Teaching  &  General  Hospital,  Gulbarga 
attached  to  M.R.  Medical  College,  Gulbarga 
during  the  period  between  April  2004  to 
February 2006 and also in Government General 
hospital  Gulbarga  attached  to  M.R.  Medical 
College,  Gulbarga  from  April  2004  to  January 
2005 were selected. All the participants in the 
present  study  gave  informed  consent  and  the 
study  was  approved  by  the  institutional  ethics 
committee.  
 
The  cases  were  selected  based  on  the 
following criteria 
1.  Age more than 12 years 
2.  Only  fresh  cases  were  taken,  old  partially 
treated cases were excluded. 
3.  Patient  should  not  have  received  any 
specific therapy outside the hospital. 
4.  Some cases whose clinical picture is similar 
to meningitis like subarachnoid hemorrhage, 
cerebral  malaria  were  excluded  after 
relevant investigations.  
Of  the  selected  fifty-four  cases,  thirty  cases 
were of tuberculous meningitis and ten cases of 
pyogenic  meningitis  and  fourteen  cases  of 
aseptic meningitis.  Fifteen patients without any 
neurological  disorders  who  needed  spinal 
anesthesia  were  included  as  controls.  All  the 
cases were thoroughly  
 
examined  clinically  by  performed  proforma 
and investigated as follows 
Ahuja et al
5 used a set of criteria using clinical 
features,  CSF  examination,  CT  findings  and 
evidence of extra neural tuberculosis to divide 
suspected  tuberculous  meningitis  patients  into 
highly  probable,  probable  and  possible 
tuberculous  meningitis  groups,  and  tested  its 
validation using bacterial isolation, polymerase 
chain  reaction  (PCR)  test  for  tuberculosis, 
response  to  treatment  and  autopsy  and found 
them  reliable  in  making  early  diagnosis  of 
tuberculous  meningitis.  In  the  present  study, 
these valid set of criteria are used to categorize 
tuberculous meningitis patients. 
 
The criteria are as follows: 
 
A) Clinical features 
•  Fever and headache more than 14 days 
(mandatory) 
•  Vomiting,  alteration  of  sensorium,  focal 
deficits (optional). 
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B) CSF showing 
•  Pleocytosis with more than 20 cells 
•  More than 60% lymphocytes 
•  Sugar  less  than  60%  of  corresponding 
blood sugar 
•  Negative Indian ink preparation studies 
•  Malignant cytology (when relevant) 
C) CT showing one or more of 
•  Exudates in basal cistern 
•  Hydrocephalus 
•  Infarcts 
•  Gyral enhancement 
D) Active  extraneural  tuberculosis  as 
evidenced by appropriate 
•  Radiological tests 
•  Microbiological tests or 
•  Ceseation  necrosis  on  histopathological 
examination. 
 
Tuberculous meningitis subgroups 
Based  on  the  above  criteria  the  following 
classification is made 
1.   Highly probable ...................... A  +  all  of  B, 
C, D 
2.  Probable  ................................. A  +  any  2  of 
B, C, D 
3.  Possible  .................................. A  +  any  1  of 
B, C, D 
 
Diagnosis of Pyogenic Meningitis 
It  is  done  by  Gram’s  staining  and  culture  of 
CSF. 
 
CSF ADA Activity 
CSF-ADA activity was estimated in all fifty-four 
cases  spectrophotometrically  by  Guisti  and 
Galanti  method  and  comparison  is  made 
between  the  levels  in  tuberculous  meningitis, 
pyogenic  meningitis,  aseptic  meningitis  and 
controls.   ADA  is  reported  to  be  stable  in 
serum  for  3  days  at  2-8ºC  and  in  biological 
fluids for 2 days at 2-8ºC, as after this, ammonia 
may be released in the samples even without 
any microbial contamination. 
 
Reference Values 
 
CSF  Normal  < 10 U/L 
Positive  > 10 U/L 
 
It  is  recommended  that  each  laboratory  establish  its  own  normal  range  representing  its  patient 
population. 
 
RESULTS 
 
A total of 30 patients were studied (02 highly 
probable,  08  probable  &  20  possible  cases) 
based  on  the  classification  of  tuberculosis 
meningitis patients using Ahuja clinical criteria 
as shown in Table-1. Among the 30 patients 17 
were  males  47.05%  &  13  were  females 
43.33%  peak  incidence  is  seen  in  the  age 
group of 21-30 years as depicted in Table-2. 
The mean CSF ADA levels  were significantly 
higher in TB meningitis group (n=30) 14.1 U/L, 
when  compared  with  Pyogenic  meningitis 
group  (n=10)  4.92  U/L,  Aseptic  meningitis 
group  (n=14)  3.66  U/L  and  control  group 
(n=15) 1.69 U/L as shown in Table-3. As per 
Table-4 there is no statistical difference in the 
CSF-ADA levels in culture positive and culture 
negative  tuberculosis  meningitis  cases.  The 
CSF sugar values were less than 40 mg% in 
26 cases, and more than 40mg% in 4 cases of 
TB  meningitis  group.  There  is  no  correlation 
between  CSF  sugar  and  CSF  ADA  levels  as 
shown in Table-5. The CSF protein levels in TB 
meningitis group showed direct correlation with 
CSF  ADA  levels  as  depicted  in  Table-6, 
similarly direct correlation was found between 
CSF lymphocyte count and CSF ADA levels in 
TB  meningitis  group  as  shown  in  Table-7. 
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activity and comparing with CSF ADA levels in 
controls,  a  sensitivity  of  100%  specificity  of 
97.44%  with  a  positive  predictive  value  of 
100% is obtained for this test. 
 
Table-1 
Classification of tuberculous meningitis patients using Ahuja Clinical Criteria 
 
TBM sub-groups  No. of 
patients 
Clinical 
criteria 
Supportive 
CSF routine 
microscopy 
CT 
positive 
cases 
Evidence of 
extra neural 
tuberculosis 
Highly probable   (A+ all of 
B,C,D) 
2  2  2  2  2 
Probable (A+ any 2 of B,C,D)  8  8  8  6  2 
Possible (A+ any 1 of B,C,D)  20  20  14  2  4 
   
Table-2 
Age wise distribution of Cases 
 
Age in years  Male  Female  Total 
No.  Percent  No.  Percent  No.  Percent 
≤ 10  --  --  --  --  --  -- 
11 – 20  5  29.41  4  30.76  9  30.00 
21 – 30  8  47.05  5  38.46  13  43.33 
31 – 40  4  23.52  3  23.07  7  23.33 
41 – 50  --  --  1  7.69  1  3.33 
>50  --  --  --  --  --  -- 
Total  17  100.00  13  100.00  30  100.00 
   
Table-3 
CSF ADA levels in different groups 
 
Group  No. of 
cases 
CSF ADA Levels (U/L) 
Mean  SD  Range 
A-TB meningitis  30  14.1  1.96  10.2-17.2 
B-Pyogenic meningitis  10  4.92  1.27  3-10.1 
C-Aseptic meningitis  14  3.66  1.03  1.2-4.9 
D-controls  15  1.69  0.44  1-2.5 
                    A Vs B,  t=13.84,    df=38,    p<0.001 
                     A Vs C,  t=18.71              df=42    p<0.001 
                     A Vs D,  t=24.02              df=43    p<0.001 
 
Table-4 
CSF ADA levels in TB Meningitis in relation to CSF culture 
 
CSF culture  No. of 
cases 
CSF ADA Levels (U/L) 
Mean  SD  Range 
Positive  4  14.04  1.96  10.2-17.2 
Negative  26  14.45  2.20  11.8-16.5 
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Table-5 
CSF ADA levels in TB meningitis in relation to CSF sugar 
 
CSF sugar (mg%)  No. of 
cases 
CSF ADA Levels (U/L) 
Mean  SD  Range 
Less than 40  26  14.19  1.97  10.2-17.2 
More than 40  4  13.7  2.05  11.8-16.50 
                    t=0.52,    df=28    p>0.05 
 
Table-6 
CSF ADA levels in TB meningitis in relation to CSF proteins 
 
Protein (mg%)  No. of 
cases 
CSF ADA Levels (U/L) 
Mean  SD  Range 
A: 0-100  8  11.76  0.99  10.2-13.5 
B: 101-200  11  14.06  1.35  12.4-16.5 
C: >200  11  15.82  0.99  14.8-17.2 
                    A Vs B,  t=5.22,     df=17,  p<0.001 
                        A Vs C,t=11.32     df=17    p<0.001   
                        B Vs C,t=4.14         df=20  p<0.001 
 
Table-7 
CSF ADA levels in TB meningitis in relation to CSF lymphocyte count 
 
Lymphocyte count 
(%) 
No. of 
cases 
CSF ADA Levels (U/L) 
Mean  SD  Range 
A: 0 – 50  3  10.8  0.65  10.2 – 11.5 
B: 51 – 70  5  12.66  0.79  11.8 – 13.5 
C: 71 – 90  12  14.72  1.32  11.8- 16.5 
D: 91 – 100  10  15.05  1.91  12.4 – 17.2 
                      A Vs B,t=7.24,               df=7,     p<0.001 
                          A Vs C,  t=7.11    df=13    p<0.001 
                          B Vs D,  t=5.83    df=11    p<0.001 
 
Table-8 
Calculation of sensitivity, specificity and positive predictive value for CSF ADA 
 in diagnosis of tuberculous meningitis 
 
Cut off 
value 
TBM 
group 
(n=30) 
Non-TBM 
group 
(n=39) 
Sensitivity  Specificity 
Positive 
predictive 
value 
≥ 10 U/L  30  1  100%  97.44%  96.77% 
                    TBM   30 Cases 
                     PYOM  10 cases 
                     ASPM  14 cases 
                    Controls  15 cases 
                   Total  39 cases 
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DISCUSSION 
Thirty  patients  of  tuberculous  meningitis  are 
studied in detail and diagnostic ability of ADA is 
evaluated  in  comparison  with  ten  cases  of 
pyogenic meningitis, fourteen cases of aseptic 
meningitis  and  fifteen  patients  without  any 
neurological  disorders  who  needed  spinal 
anesthesia. The peak incidence in the present 
study  was  found  in  young  adults  in  the  age 
group  of  21-30  years  (43%).    It  is  similar  to 
Virmani  et  al
6  who  observed  35.5%  in  their 
study.   According  to  the  present  study,  the 
incidence in males was 56.66% and in females 
43.33%.  The  incidence  in  both  males  and 
females  is  consistent  with  the  study  done  by 
Gambhir et al
7.In the present study, history of 
fever  is  present  in  all  the  cases  (100%).  It  is 
low-grade, more in the evening, associated with 
night  sweats.  In  Khatua  et  al
8  study  the 
incidence of fever was 87%, while it was 58.9% 
in the study carried out by Virmani et al
6. In the 
present study, 6 cases i.e., 20% had the past 
history of tuberculosis, whereas in Ahuja et al
5 
study, it was 10%. In the present study, there 
are  two  highly  probable  cases,  eight  probable 
cases and twenty possible cases of tuberculous 
meningitis.    This  is  almost  consistent  with 
Gambhir et al
7 study, but there were no cases in 
highly probable group in that study. Mean CSF 
ADA  level  was  significantly  higher  in  TBM 
patients  (14.1±1.96)  as  compared  to  pyogenic 
meningitis  (4.92±1.27),  aseptic  meningitis 
(3.66±1.03) and controls (1.69±.44). In Gambhir 
et  al
7  study,  mean  CSF  ADA  level  in  TBM 
patients  was  9.61±4.10  U/L  and  was 
significantly  elevated  as  compared  to  viral 
encephalitis and enteric encephalopathy cases. 
In  the  study  of  Prasad  et  al
9,  the  mean  CSF 
ADA  levels  were  6.43±1.93,  1.89±0.91, 
0.90±0.45  and  0.64±0.57  U/l  in  tuberculous 
meningitis,  pyogenic  meningitis,  aseptic 
meningitis and controls respectively. Ribera E et 
al
10  found  that  the  mean  CSF  ADA  values  in 
tuberculous  meningitis  (15.7±4.3  U/L)  which 
was  clearly  higher  than  for  the  other  patients 
(1.4±1.5 U/L).Malan C et al
11studied 30 cases of 
tuberculous  meningitis.  CSF-ADA  levels 
differentiated tuberculous meningitis cases from 
those with asceptic meningitis being higher than 
4U/l in all and higher than 6 U/L in 90% of cases 
of tuberculous meningitis, but lower than 4U/l in 
normal controls. 
  Mishra OP et al
12 found that mean CSF-
ADA  level  was  significantly  raised  in  TBM  as 
compared  to  partially  treated  bacterial 
meningitis  patients.  The  CSF  ADA  values  in 
pyogenic  meningitis  cases  are  intermediate  to 
the  respective  values  of  Gambhir  et  al
7  and 
Prasad et al
9.   In  the  aseptic  meningitis 
group,  the  values  of  ADA  are  higher  as 
compared with the respective values in Prasad 
et  al
9,  but  not  in  the  range  of  tuberculous 
meningitis  group,  as  well  as  ADA  levels  in 
control groups of the present study were higher 
when compared to the values of Prasad et al
9. 
The ADA values in tuberculous meningitis group 
in  the  present  study  when  compared  with  the 
ADA  levels  in  other  groups  such  as  pyogenic 
meningitis, aseptic meningitis and controls, the 
p-value  was  <0.001  and  is  statistically 
significant. There was no statistical difference in 
the  CSF-ADA  levels  in  culture  positive  and 
culture  negative  tuberculous  meningitis  cases.  
Similar observation was made by Prasad et al
9. 
The CSF sugar levels also did not produce any 
significant difference.  Similar observation was 
made by Prasad et al
9. CSF protein levels were 
raised  in  all  the  cases  of  TBM.    When  the 
protein  levels  were  compared  with  CSF-ADA 
levels, there was significant correlation between 
CSF ADA levels and CSF protein levels.  These 
findings  are  consistent  with  the  findings  of 
Prasad et al
9 study and Gambhir et al
7 study. 
CSF lymphocyte counts raised in all the cases. 
There  is  a  definitive  correlation  between  the 
CSF ADA values and lymphocyte count.  This is 
simple to explain as the adenosine enzyme is 
required  for  T-lymphocyte  proliferation  and 
differentiation.  The findings of the present study 
are consistent with Prasad et al
9 and Gambhir 
et al
7 studies. In the present study by using cut-
off  value  of  10  U/L,  the  test  has  sensitivity  of 
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consistent  with  Prasad  et  al
9  who  observed  a 
sensitivity  of  100%  and  specificity  of  97.5% 
using 3.3 IU/L as cut-off values.  According to 
Gambhir et al
7 using 8 IU/L as cut-off value for 
diagnosis  of  TBM  a  sensitivity  of  44%  and 
specificity of 75% was observed.  According to 
Ribera  E  et  al
10,  the  sensitivity  of  the  test  for 
diagnosing  tuberculous  meningitis  was  1  and 
specificity  0.99.  Mishra  OP  et  al
12  found  a 
sensitivity  of  62.5%  and  specificity  of  88.9%. 
The  test  can  be  of  great  aid  in  reaching  a 
presumptive  diagnosis  when  spinal  puncture 
fails to show a reduced glucose content or other 
characteristic clues in the CSF.  The adenosine 
deaminase  test  is  a  simple  and  low-cost 
procedure  that  may  be  included  as  a  routine 
laboratory method, especially in those countries 
with  a  high  prevalence  of  tuberculosis.  It  is 
therefore, evident that determining ADA level in the 
CSF is a simple and very useful test for the early 
diagnosis of tuberculous meningitis. 
 
 
CONCLUSION 
 
This  study  was  undertaken  to  evaluate  the 
diagnostic  utility  of  CSF-ADA  activity  in 
tuberculous  meningitis.  Thirty  cases  of 
tuberculous meningitis were studied. The mean 
CSF ADA value in tuberculous meningitis was 
statistically  significant  (p<0.001)  when 
compared to the CSF ADA values in pyogenic 
meningitis,  aseptic  meningitis  and  controls. 
CSF  ADA  levels  correlated  with  CSF 
lymphocyte  count  and  protein  levels  but  not 
with sugar levels. Taking the cutoff value of 10 
U/L,  the  CSF  ADA  estimation  in  tuberculous 
meningitis  has  a  sensitivity  of  100%  and 
specificity  of  97.44%  in  the  present  study. 
Though the number of the controls, pyogenic 
meningitis and aseptic meningitis cases in this 
study is small, adenosine deaminase activity in 
CSF is a rapid, relatively inexpensive and easy 
procedure, can be of great value in the early 
diagnosis  of  tuberculous  meningitis,  help  in 
earlier institution of appropriate treatment and 
thereby prevent mortality and complications. 
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